Cleared Traditional

ASPERGILLUS FUMIGATUS, ASPERGILLUS FLAVU (K790672) - FDA 510(k) Clearance

Class I Microbiology device.

K790672 · Diagnostica, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1979
Decision
55d
Days
Class 1
Risk

K790672 is an FDA 510(k) clearance for the ASPERGILLUS FUMIGATUS, ASPERGILLUS FLAVU. Classified as Antigen, Cf, Aspergillus Spp. (product code JWT), Class I - General Controls.

Submitted by Diagnostica, Inc. (Mchenry, US). The FDA issued a Cleared decision on May 31, 1979 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3040 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostica, Inc. devices

Submission Details

510(k) Number K790672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1979
Decision Date May 31, 1979
Days to Decision 55 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 102d · This submission: 55d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JWT Antigen, Cf, Aspergillus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3040
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.